Introduction:Basic information about CAS 69-25-0|Eledoisin acetate salt, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | Eledoisin acetate salt |
|---|
| CAS Number | 69-25-0 | Molecular Weight | 1188.396 |
|---|
| Density | 1.3±0.1 g/cm3 | Boiling Point | 1618.1±65.0 °C at 760 mmHg |
|---|
| Molecular Formula | C54H85N13O15S | Melting Point | / |
|---|
| MSDS | / | Flash Point | 932.4±34.3 °C |
|---|
Names
| Name | Eledoisin |
|---|
| Synonym | More Synonyms |
|---|
Eledoisin acetate salt BiologicalActivity
| Description | Eledoisin is a specific agonist of NK2 and NK3 receptors. Sequence: {Glp}-Pro-Ser-Lys-Asp-Ala-Phe-Ile-Gly-Leu-Met-NH2. |
|---|
| Related Catalog | Signaling Pathways >>Others >>OthersResearch Areas >>OthersPeptides |
|---|
| Target | NK2 and NK3 receptors[1]. |
|---|
| In Vitro | Eledoisin increases the value recorded under basal conditions by 24.5±3.7%; this stimulation is significantly (P<0.01) lowered to 13.1±1.9% by the simultaneous presence of CP99994. The same protocol is also used to characterize the sensitivity of Eledoisin stimulation to 0.1 μM SR48968 or 0.1 μM SB222200. SR48968 significantly (P < 0.01) lower the stimulation by Eledoisin, while SB222200 has no effect. Eledoisin stimulation is reduced by CP99994 and SR48968, NK1 and NK2 antagonists, respectively[1]. |
|---|
| In Vivo | Eledoisin (0.1-1 nmol/kg) injected into rats produces a biphasic cardiovascular response that consists of an initial fall of systemic blood pressure (8-15 mm Hg) followed by a rise (20-22 mm Hg). Intracerebroventricular injection of Eledoisin produces an enhancement of grooming and scratching behavior in mice[2]. |
|---|
| References | [1]. Lippe C, et al. Eledoisin and Kassinin, but not Enterokassinin, stimulate ion transport in frog skin. Peptides. 2004 Nov;25(11):1971-5. [2]. Severini C, et al. The tachykinin peptide family. Pharmacol Rev. 2002 Jun;54(2):285-322. |
|---|
Chemical & Physical Properties
| Density | 1.3±0.1 g/cm3 |
|---|
| Boiling Point | 1618.1±65.0 °C at 760 mmHg |
|---|
| Molecular Formula | C54H85N13O15S |
|---|
| Molecular Weight | 1188.396 |
|---|
| Flash Point | 932.4±34.3 °C |
|---|
| Exact Mass | 1187.600830 |
|---|
| PSA | 463.25000 |
|---|
| LogP | -1.36 |
|---|
| Vapour Pressure | 0.0±0.3 mmHg at 25°C |
|---|
| Index of Refraction | 1.569 |
|---|
| InChIKey | AYLPVIWBPZMVSH-FCKMLYJASA-N |
|---|
| SMILES | CCC(C)C(NC(=O)C(Cc1ccccc1)NC(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C1CCCN1C(=O)C1CCC(=O)N1)C(=O)NCC(=O)NC(CC(C)C)C(=O)NC(CCSC)C(N)=O |
|---|
| Storage condition | −20°C |
|---|
Toxicological Information
CHEMICAL IDENTIFICATION - RTECS NUMBER :
- JX8688000
- CHEMICAL NAME :
- Eledoisin
- CAS REGISTRY NUMBER :
- 69-25-0
- LAST UPDATED :
- 199709
- DATA ITEMS CITED :
- 1
- MOLECULAR FORMULA :
- C54-H85-N13-O15-S
- MOLECULAR WEIGHT :
- 1188.58
HEALTH HAZARD DATAACUTE TOXICITY DATA - TYPE OF TEST :
- LDLo - Lowest published lethal dose
- ROUTE OF EXPOSURE :
- Subcutaneous
- SPECIES OBSERVED :
- Mammal - dog
- DOSE/DURATION :
- 300 ug/kg
- TOXIC EFFECTS :
- Cardiac - other changes Vascular - BP lowering not characterized in autonomic section
- REFERENCE :
- EXPEAM Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945- Volume(issue)/page/year: 18,58,1962
|
Safety Information
| WGK Germany | 3 |
|---|
| RTECS | JX8688000 |
|---|
Synonyms
| 5-Oxo-L-prolyl-L-prolyl-L-seryl-L-lysyl-L-α-aspartyl-L-alanyl-L-phenylalanyl-L-isoleucylglycyl-L-leucyl-L-methioninamide |
| PGLU-PRO-SER-LYS-ASP-ALA-PHE-ILE-GLY-LEU-MET-NH2 |
| ELEDOSIN |
| GLP-PRO-SER-LYS-ASP-ALA-PHE-ILE-GLY-LEU-MET-NH2 |
| PYR-PRO-SER-LYS-ASP-ALA-PHE-ILE-GLY-LEU-MET-NH2 |
| eledonepeptide |
| 5-Oxo-L-prolyl-L-prolyl-L-seryl-L-lysyl-L-aspartyl-L-alanyl-L-phenylalanyl-L-isoleucylglycyl-L-leucyl-L-methioninamide |
| Eledone peptide |
| L-methioninamide, 5-oxo-L-prolyl-L-prolyl-L-seryl-L-lysyl-L-α-aspartyl-L-alanyl-L-phenylalanyl-L-isoleucylglycyl-L-leucyl- |
| pEPSKDAFIGLM-NH2 |
| FI 6225 TF/Ocoa |
| 5-Oxo-L-Pro-L-Pro-L-Ser-L-Lys-L-Asp-L-Ala-L-Phe-L-Ile-Gly-L-Leu-L-Met-NH2 |
| PYR-PSKDAFIGLM-NH2 |
| eledoisin |
| Eledoisin Acetate |